[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fOnDCd4pi6LhHilxVTnTCq9TGcZFwNm6Pw9WcqTGMBoA":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":33,"phaseBuckets":44,"rows":51},"Hospital Universitari de Bellvitge",[4],117,false,30,5,11146849,3,95,[14,17,20,22,24,26,29,31],{"name":15,"count":16},"Breast Cancer",7,{"name":18,"count":19},"Heart Failure",6,{"name":21,"count":9},"Biliary Tract Neoplasms",{"name":23,"count":9},"Morbid Obesity",{"name":25,"count":9},"Pancreatic Cancer",{"name":27,"count":28},"Malignant Biliary Obstruction",4,{"name":30,"count":28},"Acute Kidney Injury",{"name":32,"count":28},"Obesity",[34,39],{"nctId":35,"briefTitle":36,"date":37,"intervention":38},"NCT06851910","Intravenous Lacosamide for the Treatment of Acute Pain in Trigeminal Neuralgia","2026-12","Lacosamide",{"nctId":40,"briefTitle":41,"date":42,"intervention":43},"NCT07462663","SHAPE-ENDO: Multimodal Pre-Surgical Optimization in Patients With Obesity and Early-Stage Endometrial Cancer (Phase 1)","2027-05","GLP-1 Receptor Agonist",[45,46,47,48,49,50],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[52,85,103,125,182,207,231,257,275,302,320,348,366,384,402,420,446,472,490,518,536,563,581,599,625,652,677,703,728,753,778],{"intervention":43,"totalTrials":53,"cells":54},1,{"EARLY_PHASE1":55,"PHASE1":58,"PHASE2":60,"PHASE3":62,"PHASE4":64,"NA":83},{"trials":56,"activeCount":57},[],0,{"trials":59,"activeCount":57},[],{"trials":61,"activeCount":57},[],{"trials":63,"activeCount":57},[],{"trials":65,"activeCount":53,"soonestReadout":42},[66],{"nctId":40,"briefTitle":41,"status":67,"phases":68,"primaryCompletion":42,"completion":69,"start":70,"enrollment":71,"conditions":72,"interventions":81},"NOT_YET_RECRUITING",[49],"2028-09","2026-09",82,[73,74,75,76,77,78,79,32,80],"Endometrial Cancer","Endometrial Cancer Stage I","Atypical Endometrial Hyperplasia and Endometrial Carcinoma Stage I","Atypical Endometrial Hyperplasia","Endometrial Intraepithelial Neoplasia","Obesity & Overweight","BMI>40","Obesity Grade III",[43,82],"Oral Progestins",{"trials":84,"activeCount":57},[],{"intervention":82,"totalTrials":53,"cells":86},{"EARLY_PHASE1":87,"PHASE1":89,"PHASE2":91,"PHASE3":93,"PHASE4":95,"NA":101},{"trials":88,"activeCount":57},[],{"trials":90,"activeCount":57},[],{"trials":92,"activeCount":57},[],{"trials":94,"activeCount":57},[],{"trials":96,"activeCount":53,"soonestReadout":42},[97],{"nctId":40,"briefTitle":41,"status":67,"phases":98,"primaryCompletion":42,"completion":69,"start":70,"enrollment":71,"conditions":99,"interventions":100},[49],[73,74,75,76,77,78,79,32,80],[43,82],{"trials":102,"activeCount":57},[],{"intervention":38,"totalTrials":53,"cells":104},{"EARLY_PHASE1":105,"PHASE1":107,"PHASE2":109,"PHASE3":111,"PHASE4":113,"NA":115},{"trials":106,"activeCount":57},[],{"trials":108,"activeCount":57},[],{"trials":110,"activeCount":57},[],{"trials":112,"activeCount":57},[],{"trials":114,"activeCount":57},[],{"trials":116,"activeCount":53,"soonestReadout":37},[117],{"nctId":35,"briefTitle":36,"status":118,"phases":119,"primaryCompletion":37,"completion":42,"start":120,"enrollment":121,"conditions":122,"interventions":124},"RECRUITING",[],"2025-04-21",20,[123],"Trigeminal Neuralgia",[38],{"intervention":126,"totalTrials":11,"cells":127},"Saline Solution",{"EARLY_PHASE1":128,"PHASE1":130,"PHASE2":132,"PHASE3":134,"PHASE4":149,"NA":180},{"trials":129,"activeCount":57},[],{"trials":131,"activeCount":57},[],{"trials":133,"activeCount":57},[],{"trials":135,"activeCount":57},[136],{"nctId":137,"briefTitle":138,"status":139,"phases":140,"primaryCompletion":141,"completion":141,"start":142,"enrollment":143,"conditions":144,"interventions":147},"NCT03676556","To Evaluate Reduction of Pain in Wounds Treatment Previously Applying Lidocaine Topical Solution vs Placebo.","UNKNOWN",[48],"2023-10","2021-06-16",46,[145,146],"Wound","Anesthesia, Local",[148,126],"Lidocaine",{"trials":150,"activeCount":57},[151,166],{"nctId":152,"briefTitle":153,"status":154,"phases":155,"primaryCompletion":156,"completion":156,"start":157,"enrollment":158,"conditions":159,"interventions":163},"NCT01075646","Local Anesthesia Versus Saline Serum in Surgical Incision of Colorectal or Hepatic Surgery","COMPLETED",[49],"2014-06","2009-03",225,[160,161,162],"Postoperative Pain","Surgery","Postoperative Complications",[164,165],"ropivacaine","saline solution",{"nctId":167,"briefTitle":168,"status":169,"phases":170,"primaryCompletion":171,"completion":172,"start":173,"enrollment":16,"conditions":174,"interventions":177},"NCT02584335","To Evaluate Reduction of Pain in Wounds Treatment Previously Applying Lidocaine Topical Solution vs Placebo","TERMINATED",[49],"2016-05","2016-06","2015-07",[175,176],"Wounds","Local Anesthesia",[178,179],"Lidocaine solution","Saline solution",{"trials":181,"activeCount":57},[],{"intervention":183,"totalTrials":53,"cells":184},"PHARMACOTHERAPY",{"EARLY_PHASE1":185,"PHASE1":187,"PHASE2":189,"PHASE3":191,"PHASE4":193,"NA":205},{"trials":186,"activeCount":57},[],{"trials":188,"activeCount":57},[],{"trials":190,"activeCount":57},[],{"trials":192,"activeCount":57},[],{"trials":194,"activeCount":57},[195],{"nctId":196,"briefTitle":197,"status":169,"phases":198,"primaryCompletion":199,"completion":199,"start":200,"enrollment":201,"conditions":202,"interventions":204},"NCT01305707","Continuation Electroconvulsive Therapy (C-ECT) for Relapse Prevention in Major Depression",[49],"2014-07","2009-07",104,[203],"Depression",[183],{"trials":206,"activeCount":57},[],{"intervention":208,"totalTrials":53,"cells":209},"Drug conversion from Tacrolimus",{"EARLY_PHASE1":210,"PHASE1":212,"PHASE2":214,"PHASE3":216,"PHASE4":218,"NA":229},{"trials":211,"activeCount":57},[],{"trials":213,"activeCount":57},[],{"trials":215,"activeCount":57},[],{"trials":217,"activeCount":57},[],{"trials":219,"activeCount":57},[220],{"nctId":221,"briefTitle":222,"status":154,"phases":223,"primaryCompletion":224,"completion":224,"start":171,"enrollment":225,"conditions":226,"interventions":228},"NCT02961608","Conversion Pharmacodynamic Study in Stable Renal Transplant Patients Receiving Tacrolimus Two Times a Day to a New Formulation of Tacrolimus - LCP Tacro - 1 Time a Day.",[49],"2018-09",25,[227],"Kidney Transplant; Complications",[208],{"trials":230,"activeCount":57},[],{"intervention":232,"totalTrials":53,"cells":233},"tinzaparin",{"EARLY_PHASE1":234,"PHASE1":236,"PHASE2":238,"PHASE3":240,"PHASE4":242,"NA":255},{"trials":235,"activeCount":57},[],{"trials":237,"activeCount":57},[],{"trials":239,"activeCount":57},[],{"trials":241,"activeCount":57},[],{"trials":243,"activeCount":57},[244],{"nctId":245,"briefTitle":246,"status":154,"phases":247,"primaryCompletion":248,"completion":248,"start":249,"enrollment":250,"conditions":251,"interventions":253},"NCT00689520","Long-Term Low-Molecular-Weight Heparin Versus Oral Anticoagulants in Deep Venous Thrombosis",[49],"2005-01","2002-01",241,[252],"Venous Thromboembolism",[232,254],"acenocoumarol",{"trials":256,"activeCount":57},[],{"intervention":254,"totalTrials":53,"cells":258},{"EARLY_PHASE1":259,"PHASE1":261,"PHASE2":263,"PHASE3":265,"PHASE4":267,"NA":273},{"trials":260,"activeCount":57},[],{"trials":262,"activeCount":57},[],{"trials":264,"activeCount":57},[],{"trials":266,"activeCount":57},[],{"trials":268,"activeCount":57},[269],{"nctId":245,"briefTitle":246,"status":154,"phases":270,"primaryCompletion":248,"completion":248,"start":249,"enrollment":250,"conditions":271,"interventions":272},[49],[252],[232,254],{"trials":274,"activeCount":57},[],{"intervention":276,"totalTrials":53,"cells":277},"Gastrografin",{"EARLY_PHASE1":278,"PHASE1":280,"PHASE2":282,"PHASE3":284,"PHASE4":286,"NA":300},{"trials":279,"activeCount":57},[],{"trials":281,"activeCount":57},[],{"trials":283,"activeCount":57},[],{"trials":285,"activeCount":57},[],{"trials":287,"activeCount":57},[288],{"nctId":289,"briefTitle":290,"status":154,"phases":291,"primaryCompletion":292,"completion":293,"start":294,"enrollment":295,"conditions":296,"interventions":298},"NCT01440712","Study of the Effect of Water Soluble Oral Contrast (Gastrografin) on Postoperative Ileus After Colorectal Surgery",[49],"2013-11","2013-12","2011-12",58,[297],"Postoperative Ileus",[276,299],"physiological serum",{"trials":301,"activeCount":57},[],{"intervention":299,"totalTrials":53,"cells":303},{"EARLY_PHASE1":304,"PHASE1":306,"PHASE2":308,"PHASE3":310,"PHASE4":312,"NA":318},{"trials":305,"activeCount":57},[],{"trials":307,"activeCount":57},[],{"trials":309,"activeCount":57},[],{"trials":311,"activeCount":57},[],{"trials":313,"activeCount":57},[314],{"nctId":289,"briefTitle":290,"status":154,"phases":315,"primaryCompletion":292,"completion":293,"start":294,"enrollment":295,"conditions":316,"interventions":317},[49],[297],[276,299],{"trials":319,"activeCount":57},[],{"intervention":321,"totalTrials":53,"cells":322},"Piperacillin-Tazobactam 4 g-0.5 g",{"EARLY_PHASE1":323,"PHASE1":325,"PHASE2":327,"PHASE3":329,"PHASE4":331,"NA":346},{"trials":324,"activeCount":57},[],{"trials":326,"activeCount":57},[],{"trials":328,"activeCount":57},[],{"trials":330,"activeCount":57},[],{"trials":332,"activeCount":57},[333],{"nctId":334,"briefTitle":335,"status":139,"phases":336,"primaryCompletion":337,"completion":338,"start":339,"enrollment":340,"conditions":341,"interventions":343},"NCT04233996","Efficacy of Extended Infusion of β-lactam Antibiotics for the Treatment of Febrile Neutropenia in Hematologic Patients",[49],"2021-12-30","2022-12-31","2019-06-05",150,[342],"Febrile Neutropenia",[321,344,345],"Cefepime 2000 mg","Meropenem 1000 mg",{"trials":347,"activeCount":57},[],{"intervention":344,"totalTrials":53,"cells":349},{"EARLY_PHASE1":350,"PHASE1":352,"PHASE2":354,"PHASE3":356,"PHASE4":358,"NA":364},{"trials":351,"activeCount":57},[],{"trials":353,"activeCount":57},[],{"trials":355,"activeCount":57},[],{"trials":357,"activeCount":57},[],{"trials":359,"activeCount":57},[360],{"nctId":334,"briefTitle":335,"status":139,"phases":361,"primaryCompletion":337,"completion":338,"start":339,"enrollment":340,"conditions":362,"interventions":363},[49],[342],[321,344,345],{"trials":365,"activeCount":57},[],{"intervention":345,"totalTrials":53,"cells":367},{"EARLY_PHASE1":368,"PHASE1":370,"PHASE2":372,"PHASE3":374,"PHASE4":376,"NA":382},{"trials":369,"activeCount":57},[],{"trials":371,"activeCount":57},[],{"trials":373,"activeCount":57},[],{"trials":375,"activeCount":57},[],{"trials":377,"activeCount":57},[378],{"nctId":334,"briefTitle":335,"status":139,"phases":379,"primaryCompletion":337,"completion":338,"start":339,"enrollment":340,"conditions":380,"interventions":381},[49],[342],[321,344,345],{"trials":383,"activeCount":57},[],{"intervention":164,"totalTrials":53,"cells":385},{"EARLY_PHASE1":386,"PHASE1":388,"PHASE2":390,"PHASE3":392,"PHASE4":394,"NA":400},{"trials":387,"activeCount":57},[],{"trials":389,"activeCount":57},[],{"trials":391,"activeCount":57},[],{"trials":393,"activeCount":57},[],{"trials":395,"activeCount":57},[396],{"nctId":152,"briefTitle":153,"status":154,"phases":397,"primaryCompletion":156,"completion":156,"start":157,"enrollment":158,"conditions":398,"interventions":399},[49],[160,161,162],[164,165],{"trials":401,"activeCount":57},[],{"intervention":178,"totalTrials":53,"cells":403},{"EARLY_PHASE1":404,"PHASE1":406,"PHASE2":408,"PHASE3":410,"PHASE4":412,"NA":418},{"trials":405,"activeCount":57},[],{"trials":407,"activeCount":57},[],{"trials":409,"activeCount":57},[],{"trials":411,"activeCount":57},[],{"trials":413,"activeCount":57},[414],{"nctId":167,"briefTitle":168,"status":169,"phases":415,"primaryCompletion":171,"completion":172,"start":173,"enrollment":16,"conditions":416,"interventions":417},[49],[175,176],[178,179],{"trials":419,"activeCount":57},[],{"intervention":421,"totalTrials":53,"cells":422},"Chemotherapy- scheme",{"EARLY_PHASE1":423,"PHASE1":425,"PHASE2":427,"PHASE3":429,"PHASE4":431,"NA":444},{"trials":424,"activeCount":57},[],{"trials":426,"activeCount":57},[],{"trials":428,"activeCount":57},[],{"trials":430,"activeCount":57},[],{"trials":432,"activeCount":57},[433],{"nctId":434,"briefTitle":435,"status":169,"phases":436,"primaryCompletion":437,"completion":438,"start":293,"enrollment":439,"conditions":440,"interventions":443},"NCT02015923","Resection vs no Resection of the Primary in Colorectal Cancer With Unresectable Metastases",[49],"2019-06","2020-02",107,[441,442],"Colonic Cancer","Unresectable Metastasis Originating in Colonic Cancer",[421],{"trials":445,"activeCount":57},[],{"intervention":447,"totalTrials":53,"cells":448},"Preventive treatment with Isoniazid.",{"EARLY_PHASE1":449,"PHASE1":451,"PHASE2":453,"PHASE3":455,"PHASE4":457,"NA":470},{"trials":450,"activeCount":57},[],{"trials":452,"activeCount":57},[],{"trials":454,"activeCount":57},[],{"trials":456,"activeCount":57},[],{"trials":458,"activeCount":57},[459],{"nctId":460,"briefTitle":461,"status":154,"phases":462,"primaryCompletion":463,"completion":463,"start":464,"enrollment":465,"conditions":466,"interventions":468},"NCT01223534","QuantiFERON®-TB Gold In-Tube for the Diagnosis of Tuberculosis Infection in Contact Tracing Study.",[49],"2016-02","2010-07",871,[467],"Latent Tuberculosis Infection",[447,469],"Preventive treatment with Isoniazid",{"trials":471,"activeCount":57},[],{"intervention":469,"totalTrials":53,"cells":473},{"EARLY_PHASE1":474,"PHASE1":476,"PHASE2":478,"PHASE3":480,"PHASE4":482,"NA":488},{"trials":475,"activeCount":57},[],{"trials":477,"activeCount":57},[],{"trials":479,"activeCount":57},[],{"trials":481,"activeCount":57},[],{"trials":483,"activeCount":57},[484],{"nctId":460,"briefTitle":461,"status":154,"phases":485,"primaryCompletion":463,"completion":463,"start":464,"enrollment":465,"conditions":486,"interventions":487},[49],[467],[447,469],{"trials":489,"activeCount":57},[],{"intervention":491,"totalTrials":53,"cells":492},"Tacrolimus",{"EARLY_PHASE1":493,"PHASE1":495,"PHASE2":497,"PHASE3":499,"PHASE4":514,"NA":516},{"trials":494,"activeCount":57},[],{"trials":496,"activeCount":57},[],{"trials":498,"activeCount":57},[],{"trials":500,"activeCount":57},[501],{"nctId":502,"briefTitle":503,"status":139,"phases":504,"primaryCompletion":505,"completion":506,"start":507,"enrollment":508,"conditions":509,"interventions":512},"NCT04341038","Clinical Trial to Evaluate Methylprednisolone Pulses and Tacrolimus in Patients With COVID-19 Lung Injury",[48],"2020-06-01","2020-07-01","2020-04-01",84,[510,511],"COVID-19","Lung Injury",[491,513],"Methylprednisolone",{"trials":515,"activeCount":57},[],{"trials":517,"activeCount":57},[],{"intervention":513,"totalTrials":53,"cells":519},{"EARLY_PHASE1":520,"PHASE1":522,"PHASE2":524,"PHASE3":526,"PHASE4":532,"NA":534},{"trials":521,"activeCount":57},[],{"trials":523,"activeCount":57},[],{"trials":525,"activeCount":57},[],{"trials":527,"activeCount":57},[528],{"nctId":502,"briefTitle":503,"status":139,"phases":529,"primaryCompletion":505,"completion":506,"start":507,"enrollment":508,"conditions":530,"interventions":531},[48],[510,511],[491,513],{"trials":533,"activeCount":57},[],{"trials":535,"activeCount":57},[],{"intervention":537,"totalTrials":53,"cells":538},"Fibrinogen",{"EARLY_PHASE1":539,"PHASE1":541,"PHASE2":543,"PHASE3":545,"PHASE4":559,"NA":561},{"trials":540,"activeCount":57},[],{"trials":542,"activeCount":57},[],{"trials":544,"activeCount":57},[],{"trials":546,"activeCount":57},[547],{"nctId":548,"briefTitle":549,"status":139,"phases":550,"primaryCompletion":551,"completion":552,"start":553,"enrollment":554,"conditions":555,"interventions":557},"NCT01539057","The Efficacy of the Administration of Fibrinogen in Liver Transplantation",[48],"2013-09","2015-01","2012-07",132,[556],"Intraoperative Bleeding",[537,558],"Saline",{"trials":560,"activeCount":57},[],{"trials":562,"activeCount":57},[],{"intervention":558,"totalTrials":53,"cells":564},{"EARLY_PHASE1":565,"PHASE1":567,"PHASE2":569,"PHASE3":571,"PHASE4":577,"NA":579},{"trials":566,"activeCount":57},[],{"trials":568,"activeCount":57},[],{"trials":570,"activeCount":57},[],{"trials":572,"activeCount":57},[573],{"nctId":548,"briefTitle":549,"status":139,"phases":574,"primaryCompletion":551,"completion":552,"start":553,"enrollment":554,"conditions":575,"interventions":576},[48],[556],[537,558],{"trials":578,"activeCount":57},[],{"trials":580,"activeCount":57},[],{"intervention":148,"totalTrials":53,"cells":582},{"EARLY_PHASE1":583,"PHASE1":585,"PHASE2":587,"PHASE3":589,"PHASE4":595,"NA":597},{"trials":584,"activeCount":57},[],{"trials":586,"activeCount":57},[],{"trials":588,"activeCount":57},[],{"trials":590,"activeCount":57},[591],{"nctId":137,"briefTitle":138,"status":139,"phases":592,"primaryCompletion":141,"completion":141,"start":142,"enrollment":143,"conditions":593,"interventions":594},[48],[145,146],[148,126],{"trials":596,"activeCount":57},[],{"trials":598,"activeCount":57},[],{"intervention":600,"totalTrials":53,"cells":601},"valproic acid",{"EARLY_PHASE1":602,"PHASE1":604,"PHASE2":606,"PHASE3":608,"PHASE4":621,"NA":623},{"trials":603,"activeCount":57},[],{"trials":605,"activeCount":57},[],{"trials":607,"activeCount":57},[],{"trials":609,"activeCount":57},[610],{"nctId":611,"briefTitle":612,"status":154,"phases":613,"primaryCompletion":614,"completion":615,"start":616,"enrollment":9,"conditions":617,"interventions":620},"NCT01586208","Refractory Status Epilepticus Treatment Study",[48],"2012-05","2012-10","2010-01",[618,619],"Grand Mal Status Epilepticus","Non-convulsive Status Epilepticus",[600],{"trials":622,"activeCount":57},[],{"trials":624,"activeCount":57},[],{"intervention":626,"totalTrials":53,"cells":627},"Erythromycin",{"EARLY_PHASE1":628,"PHASE1":630,"PHASE2":632,"PHASE3":634,"PHASE4":648,"NA":650},{"trials":629,"activeCount":57},[],{"trials":631,"activeCount":57},[],{"trials":633,"activeCount":57},[],{"trials":635,"activeCount":57},[636],{"nctId":637,"briefTitle":638,"status":139,"phases":639,"primaryCompletion":640,"completion":641,"start":642,"enrollment":643,"conditions":644,"interventions":647},"NCT01716572","Erythromycin Versus Gastric Lavage to Improve Quality of Endoscopy in Patients With Upper Gastrointestinal Bleeding",[48],"2015-09","2015-12","2012-02",122,[645,646],"Gastrointestinal Hemorrhage","Hematemesis",[626],{"trials":649,"activeCount":57},[],{"trials":651,"activeCount":57},[],{"intervention":653,"totalTrials":53,"cells":654},"Citalopram",{"EARLY_PHASE1":655,"PHASE1":657,"PHASE2":659,"PHASE3":671,"PHASE4":673,"NA":675},{"trials":656,"activeCount":57},[],{"trials":658,"activeCount":57},[],{"trials":660,"activeCount":57},[661],{"nctId":662,"briefTitle":663,"status":169,"phases":664,"primaryCompletion":665,"completion":666,"start":665,"enrollment":667,"conditions":668,"interventions":670},"NCT05063604","Antidepressant Efficacy of Psychotherapy and Citalopram in Patients With Breast Cancer and Major Depression",[47],"2022-05-10","2022-06-29",40,[15,669],"Major Depressive Episode",[653],{"trials":672,"activeCount":57},[],{"trials":674,"activeCount":57},[],{"trials":676,"activeCount":57},[],{"intervention":678,"totalTrials":53,"cells":679},"Apixaban 2.5 milligram Oral",{"EARLY_PHASE1":680,"PHASE1":682,"PHASE2":684,"PHASE3":697,"PHASE4":699,"NA":701},{"trials":681,"activeCount":57},[],{"trials":683,"activeCount":57},[],{"trials":685,"activeCount":57},[686],{"nctId":687,"briefTitle":688,"status":154,"phases":689,"primaryCompletion":690,"completion":690,"start":691,"enrollment":692,"conditions":693,"interventions":696},"NCT04952792","Study of Apixaban in Patients Receiving Hemodiafiltration",[47],"2022-12-15","2021-05-20",11,[694,695],"Atrial Fibrillation","Hemodialysis Complication",[678],{"trials":698,"activeCount":57},[],{"trials":700,"activeCount":57},[],{"trials":702,"activeCount":57},[],{"intervention":704,"totalTrials":53,"cells":705},"Iron Carboxymaltose",{"EARLY_PHASE1":706,"PHASE1":708,"PHASE2":710,"PHASE3":712,"PHASE4":714,"NA":716},{"trials":707,"activeCount":57},[],{"trials":709,"activeCount":57},[],{"trials":711,"activeCount":57},[],{"trials":713,"activeCount":57},[],{"trials":715,"activeCount":57},[],{"trials":717,"activeCount":57},[718],{"nctId":719,"briefTitle":720,"status":139,"phases":721,"primaryCompletion":722,"completion":723,"start":724,"enrollment":725,"conditions":726,"interventions":727},"NCT05000853","New Pathophysiological Pathways Involved in Iron Metabolism Disorder in Heart Failure",[],"2023-07-01","2023-08-01","2021-08-01",210,[18],[704],{"intervention":729,"totalTrials":53,"cells":730},"Antibiotics",{"EARLY_PHASE1":731,"PHASE1":733,"PHASE2":735,"PHASE3":737,"PHASE4":739,"NA":741},{"trials":732,"activeCount":57},[],{"trials":734,"activeCount":57},[],{"trials":736,"activeCount":57},[],{"trials":738,"activeCount":57},[],{"trials":740,"activeCount":57},[],{"trials":742,"activeCount":57},[743],{"nctId":744,"briefTitle":745,"status":154,"phases":746,"primaryCompletion":747,"completion":747,"start":748,"enrollment":121,"conditions":749,"interventions":752},"NCT04033029","Antibiotic Plasma Concentrations During Continuous Renal Replacement Therapy With a High Adsorption Membrane (oXiris®)",[],"2023-06-30","2021-01-01",[750,751,30],"Hemodiafiltration","Sepsis",[729],{"intervention":754,"totalTrials":53,"cells":755},"intravenous iron",{"EARLY_PHASE1":756,"PHASE1":758,"PHASE2":760,"PHASE3":762,"PHASE4":764,"NA":766},{"trials":757,"activeCount":57},[],{"trials":759,"activeCount":57},[],{"trials":761,"activeCount":57},[],{"trials":763,"activeCount":57},[],{"trials":765,"activeCount":57},[],{"trials":767,"activeCount":57},[768],{"nctId":769,"briefTitle":770,"status":139,"phases":771,"primaryCompletion":772,"completion":772,"start":773,"enrollment":774,"conditions":775,"interventions":777},"NCT05187637",".Patient Blood Management Program in Liver Transplantation",[],"2023-04-24","2022-03-23",66,[776],"Iron Deficiency Anemia",[754],{"intervention":779,"totalTrials":53,"cells":780},"neuromuscular blockade",{"EARLY_PHASE1":781,"PHASE1":783,"PHASE2":785,"PHASE3":787,"PHASE4":789,"NA":791},{"trials":782,"activeCount":57},[],{"trials":784,"activeCount":57},[],{"trials":786,"activeCount":57},[],{"trials":788,"activeCount":57},[],{"trials":790,"activeCount":57},[],{"trials":792,"activeCount":57},[793],{"nctId":794,"briefTitle":795,"status":139,"phases":796,"primaryCompletion":172,"completion":797,"start":552,"enrollment":798,"conditions":799,"interventions":801},"NCT02327494","Study to Evaluate Oxygen Monitoring at Different Stages of Neuromuscular Blockade in Colorectal Surgery",[],"2017-01",70,[800],"Colorectal Cancer",[779]]